USA – Medtronic, a global leader in medical technology, has appointed Dr. Matthew Kroh as the Chief Medical Officer for its Advanced and General Surgical Technologies division.
This strategic move underscores Medtronic’s dedication to advancing surgical innovation and enhancing patient care through cutting-edge medical technology.
Dr. Kroh, a board-certified surgeon with expertise in advanced laparoscopic, bariatric, and surgical endoscopy, brings a wealth of clinical and healthcare leadership experience to his new role.
Medtronic has highlighted that Kroh’s appointment will significantly enhance its clinical strategy, deepen physician relationships, and bolster engagement with key medical societies.
“Dr. Kroh’s extensive background in pioneering surgical techniques makes him an invaluable addition to our team,” stated Justin Roberts, General Manager and Vice President of Advanced Surgical Technologies at Medtronic.
“We are thrilled to welcome him and believe his innovative approach will help push the boundaries of what’s achievable in medical technology.”
A leader in surgical innovation
Dr. Kroh’s experience as Division Chief of Foregut and Surgical Endoscopy at the Cleveland Clinic has established him as a prominent figure in minimally invasive techniques, including robotic and single-incision laparoscopic surgeries.
Notably, he conducted the first minimally invasive procedures using Levita Magnetics’ robotic surgical platform in 2023, marking a milestone in surgical innovation.
Kroh’s expertise aligns well with Medtronic’s mission to develop accessible, efficient, and patient-centered surgical solutions.
His leadership is expected to drive product development and commercialization strategies, bringing Medtronic’s advanced surgical technologies to broader clinical use.
Advancing Patient Outcomes through Innovation
Reflecting on his new role, Dr. Kroh expressed his commitment to Medtronic’s mission. “I am honored to join a company dedicated to transforming healthcare through innovation,” he said.
“I look forward to contributing to the development of surgical technologies that expand access and improve patient outcomes worldwide.”
Despite his new executive responsibilities, Dr. Kroh plans to continue practicing surgery at the Cleveland Clinic.
This dual role will allow him to stay at the forefront of clinical advancements while directly shaping Medtronic’s surgical technology initiatives.
